Cost-utility analysis of four WHO-recommended sofosbuvir-based regimens for the treatment of chronic hepatitis C in sub-Saharan Africa.
Boyer S, Baudoin M, Nishimwe ML, Santos M, Lemoine M, Maradan G, Sylla B, Kouanfack C, Carrieri P, Mourad A, Rouveau N, Moh R, Seydi M, Attia A, Woode ME, Lacombe K.
Boyer S, et al. Among authors: woode me.
BMC Health Serv Res. 2022 Mar 5;22(1):303. doi: 10.1186/s12913-021-07289-0.
BMC Health Serv Res. 2022.
PMID: 35248039
Free PMC article.